XML 58 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization (Tables)
 12 Months Ended
Dec. 31, 2023
Organization [Abstract]  
Schedule of Major Subsidiaries Consolidated Below summarizes the list of the major subsidiaries consolidated as of December 31, 2023:
Name   Incorporation
date		   Ownership   Place of
incorporation		   Principle activities
Aptorum Therapeutics Limited (“ATL”)   June 30, 2016   100%   Cayman Islands   Research and development of life science and biopharmaceutical products
APTUS MANAGEMENT LIMITED   May 16, 2017   100%   Hong Kong   Provision of management services to its holding company and fellow subsidiaries
Aptorum Medical Limited   August 28, 2017   90%   Cayman Islands   Provision of medical clinic services
Paths Innovations Limited   April 15, 2019   100%   Cayman Islands   Investment holding company
Paths Diagnostics Pte. Limited   June 5, 2019   75%   Singapore   Research and development of life science and biopharmaceutical products
Acticule Life Sciences Limited   June 30, 2017   80%   Cayman Islands   Research and development of life science and biopharmaceutical products
Claves Life Sciences Limited   August 2, 2017   100%   Cayman Islands   Research and development of life science and biopharmaceutical products
Nativus Life Sciences Limited   July 7, 2017   100%   Cayman Islands   Research and development of life science and biopharmaceutical products
Videns Incorporation Limited   March 2, 2017   100%   Cayman Islands   Research and development of life science and biopharmaceutical products
Mios Pharmaceuticals Limited   March 6, 2018   97.93%   Cayman Islands   Research and development of life science and biopharmaceutical products
mTOR (Hong Kong) Limited   November 4, 2016   90%   Hong Kong   Research and development of life science and biopharmaceutical products
Scipio Life Sciences Limited   July 19, 2017   97.93%   Cayman Islands   Research and development of life science and biopharmaceutical products
Signate Life Sciences Limited   August 28, 2017   100%   Cayman Islands   Research and development of life science and biopharmaceutical products